Ledger.Open graph →

SEC Form D · Amendment · filed March 29, 2019

Inozyme Pharma, Inc

Offering

$33.7M

Sold

$33.7M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Martin Edwards · Boston, MADirector Axel Bolte · Boston, MAExec · Director Joseph Schlessinger · Boston, MADirector Reinaldo Diaz · Boston, MADirector Sarah Bhagat · Boston, MADirector Rob Hopfner · Boston, MADirector Edward Mathers · Boston, MADirector William Bennett · Chicago, ILExec · Director Andrew Denardo · Red Bank, NJDirector Michael J. Hughes · Evanston, ILDirector Matthew Goebel · Chicago, ILDirector Robert Saunders · Chicago, ILDirector Daniel J. Hopkins · Evanston, ILDirector Michael R. Crimmins · Atlanta, GADirector Eric Huebner · Indianapolis, INDirector Sean Mullins · Indianapolis, INDirector Sean Lavies · Indianapolis, INExec · Director Harley Miller · Brooklyn, NYDirector GGV Discovery II L.L.C · Menlo Park, CADirector Robert D. Ghiselli · Glendale, CODirector Joan C. Heidorn · Bartlesville, OKDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗